- Investing Ideas
- Software Healthcare Sector
Software Healthcare Sector
Results
2168
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2168 companies
Jupiter Neurosciences
Market Cap: US$4.4m
A clinical stage research and development pharmaceutical company, engages in the development of therapeutics for central nervous system disorders and rare diseases in the United States and internationally.
JUNS
US$5.17
7D
2.2%
1Y
-95.3%
Leveljump Healthcare
Market Cap: CA$6.1m
Provides radiology services.
JUMP
CA$0.055
7D
0%
1Y
n/a
Aptevo Therapeutics
Market Cap: US$4.3m
A clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States.
APVO
US$2.46
7D
-15.2%
1Y
-92.6%
VivoSim Labs
Market Cap: US$4.3m
A pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine.
VIVS
US$0.29
7D
4.7%
1Y
-83.5%
PharmaTher Holdings
Market Cap: CA$5.9m
A specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes.
PHRM
CA$0.06
7D
9.1%
1Y
-84.4%
Zelira Therapeutics
Market Cap: AU$5.9m
A biopharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based medicines for the treatment of various medical conditions in Australia and the United States.
ZLD
AU$0.50
7D
0%
1Y
1.0%
HCW Biologics
Market Cap: US$4.2m
A clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and diseases in the United States.
HCWB
US$2.60
7D
22.1%
1Y
-92.6%
Acrux
Market Cap: AU$5.9m
Develops and commercializes generic and topically applied pharmaceutical products in Australia, Europe, the United States, and internationally.
ACR
AU$0.01
7D
0%
1Y
-33.3%
Tenon Medical
Market Cap: US$4.2m
A medical device company, engages in the development of implant for the treatment of severe lower back pain in the United States.
TNON
US$5.62
7D
3.1%
1Y
-87.7%
Mustang Bio
Market Cap: US$4.2m
A clinical-stage biopharmaceutical company, focuses on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases in the United States.
MBIO
US$0.55
7D
-3.2%
1Y
-63.4%
Silo Pharma
Market Cap: US$4.1m
Operates as a developmental stage biopharmaceutical company.
SILO
US$2.59
7D
-15.6%
1Y
-73.2%
Feedback
Market Cap: UK£3.0m
Provides software and systems to those working in the field of medical imaging.
FDBK
UK£0.069
7D
12.3%
1Y
-48.3%
Veltex
Market Cap: US$4.1m
Focuses on the development and acquisition of companies that have modalities in the areas of health, wellness, and recovery.
VLXC
US$0.04
7D
1.5%
1Y
-50.0%
WEED
Market Cap: US$4.0m
Focuses on the development and application of cannabis-derived compounds for the treatment of human diseases and animal ailments in the United States.
BUDZ
US$0.029
7D
0.9%
1Y
-17.9%
Bluejay Diagnostics
Market Cap: US$4.0m
Operates as a medical diagnostics company.
BJDX
US$0.92
7D
-5.6%
1Y
-83.2%
Me Today
Market Cap: NZ$6.7m
Through its subsidiaries, engages in the production, sale, and marketing of health and wellbeing products in New Zealand, the United States, and Europe.
MEE
NZ$0.075
7D
11.9%
1Y
29.3%
International Stem Cell
Market Cap: US$4.0m
A clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally.
ISCO
US$0.48
7D
-2.5%
1Y
291.3%
DataMEDS AI
Market Cap: US$4.0m
Operates as a health IT company in the United States.
MEDS
US$1.36
7D
-1.4%
1Y
-98.4%
iSpecimen
Market Cap: US$4.0m
Operates marketplace that provides biospecimens to life science researchers in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
ISPC
US$1.60
7D
-31.6%
1Y
-95.0%
Adherium
Market Cap: AU$5.5m
A digital health company, develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, and North America.
ADR
AU$0.10
7D
0%
1Y
-80.0%
GRI Bio
Market Cap: US$3.9m
A clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies that target diseases leading to inflammatory, fibrotic, and autoimmune disorders in the United States.
GRI
US$1.96
7D
14.6%
1Y
-95.0%
Biotron
Market Cap: AU$5.4m
A biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia.
BIT
AU$0.002
7D
0%
1Y
-33.3%
Imagion Biosystems
Market Cap: AU$5.4m
Operates as a medical imaging company that uses bio-safe magnetic nanoparticles to detect cancer and other diseases in Australia.
IBX
AU$0.011
7D
5.0%
1Y
-34.4%
SciSparc
Market Cap: US$3.9m
A clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies.
SPRC
US$6.69
7D
2.8%
1Y
-82.4%
Nuwellis
Market Cap: US$3.8m
A medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy.
NUWE
US$0.96
7D
-19.4%
1Y
-99.5%
Tissue Repair
Market Cap: AU$5.3m
A clinical stage biopharmaceutical company, develops advanced wound healing products for chronic wounds and the aftercare of cosmetic procedures in Australia.
TRP
AU$0.088
7D
6.0%
1Y
-72.9%
MYND Life Sciences
Market Cap: CA$5.2m
A life sciences-based neuro-pharmaceutical drug development company, advances medicines based on neuro-anti-inflammatory substances for depressive disorders through science and clinical trials in Canada and the United States.
MYND
CA$0.07
7D
0%
1Y
n/a
60 Degrees Pharmaceuticals
Market Cap: US$3.8m
A specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States.
SXTP
US$1.13
7D
0.9%
1Y
-77.8%
KRTL Holding Group
Market Cap: US$3.8m
A beverage and food company, engages in the production and distribution of bottled natural spring water and flavored carbonated water in North America and internationally.
KRTL
US$0.038
7D
-5.0%
1Y
-41.5%
1933 Industries
Market Cap: CA$5.2m
Engages in the cultivation, extraction, and production of cannabis products in the United States.
TGIF
CA$0.01
7D
0%
1Y
0%
NEXGEL
Market Cap: US$3.7m
Manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States.
NXGL
US$0.36
7D
-7.4%
1Y
-84.9%
Valion Bio
Market Cap: US$3.7m
Operates as a late-stage biopharmaceutical company.
VBIO
US$0.16
7D
-1.0%
1Y
-94.9%
RedHill Biopharma
Market Cap: US$3.7m
A specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases.
RDHL
US$0.61
7D
2.1%
1Y
-55.5%
XORTX Therapeutics
Market Cap: CA$5.1m
A late-stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat hyperuricemia related diseases in Canada.
XRTX
CA$3.09
7D
11.2%
1Y
-46.3%
Quantum Genesis AI
Market Cap: US$3.6m
A biotransformation company, focuses on advancing enzyme-based solutions for pharmaceutical manufacturing.
QGAI
US$0.08
7D
12.8%
1Y
-56.8%
Telo Genomics
Market Cap: CA$5.0m
A molecular diagnostics company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions, primarily in Canada.
TELO
CA$0.05
7D
11.1%
1Y
-37.5%